Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -166.00 -1.54% 10,644.00 10,660.00 10,662.00 10,874.00 10,654.00 10,784.00 2,307,484 16:35:21
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 27,668.9 -196.0 5.9 1,651.4 164,888

AstraZeneca Gets EU Approval for Ultomiris Drug

23/09/2022 7:42am

Dow Jones News

Astrazeneca (LSE:AZN)
Historical Stock Chart

From Jul 2022 to Jan 2023

Click Here for more Astrazeneca Charts.

By Sabela Ojea


AstraZeneca PLC said Friday that its Ultomiris drug has been approved in the European Union for the treatment of adults with the rare disease generalized myasthenia gravis.

The Anglo-Swedish pharma giant said that Ultomiris may reduce treatment burden with dosing every eight weeks, it said, adding that the drug also proved an improvement in activities of daily living.

Generalized myasthenia gravis is a rare autoimmune neuromuscular disease that leads to a loss of muscle function and severe weakness, AstraZeneca said.


Write to Sabela Ojea at; @sabelaojeaguix


(END) Dow Jones Newswires

September 23, 2022 02:27 ET (06:27 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20230126 21:49:15